On Friday, December 19, 2025, the Indian stock market began its session with a strong “green” opening, breaking a four-day losing streak. Investor confidence was high as the benchmark Nifty 50 climbed over the 25,900 level right from the start. As of the morning session on Friday, December 19, 2025, the Nifty Pharma index was trading at 22,718.80 (10.50 AM), reflecting a positive gain of 161.20 points (0.71%).
This upward move in the sectoral index is being spearheaded by Divi’s Laboratories, which saw a significant 3.04% jump following a major institutional block trade, alongside other pharmaceutical stocks like Biocon and Lupin. Further, IT stocks including Infosys and TCS continued their positive momentum on Friday.
Market Opening Snapshot (9:16 AM IST)
| Index | Opening Level | Change (Points) | Change (%) |
|---|---|---|---|
| Nifty 50 | 25,911.50 | +96.00 | +0.37% |
| Sensex | 84,756.80 | +274.98 | +0.33% |
| Nifty Bank | 59,047.40 | +134.55 | +0.23% |
| Nifty Midcap 100 | 59,718.60 | +126.40 | +0.21% |
(Source: NSE, BSE)
Global Factors Influencing Today’s Trade
The recovery in Indian markets was largely driven by positive news from around the world:
- Cooling US Inflation: Annual inflation in the US rose to 2.7%, which was lower than the expected 3.1%. This has raised hopes that the US Federal Reserve might cut interest rates soon.
- Bank of England Rate Cut: In a surprise “Christmas boost,” the Bank of England lowered interest rates from 4% to 3.75%.
- Japan’s Historic Move: The Bank of Japan hiked its interest rate to 0.75%, the highest level in 30 years.
- Currency and Commodities: The Indian Rupee opened slightly stronger at 90.14 against the US Dollar. Meanwhile, oil prices dropped below $60 per barrel, which is good news for India’s import costs.
(Source: CNBC TV-18, Trading Economics)
Key Stocks in Action
Divi’s Laboratories and Pharmaceutical Sector
- Divi’s Laboratories: Witnessed strong buying interest and was a major factor behind the market’s rise. A significant catalyst for the stock rise was a massive block trade executed on the National Stock Exchange (NSE) valued at ₹95.73 crore. The transaction involved 150,017 shares priced at ₹6,381.50 per-share, reflecting substantial institutional confidence in the pharmaceutical giant. As of 9:53 AM on Friday, December 19, 2025, Divi’s Laboratories Ltd (NSE: DIVISLAB) is trading at ₹6,574.00, marking a strong intraday gain of ₹194.00 (3.04%).
- Biocon: Received an EIR from the US FDA for its New Jersey facility with a “Voluntary Action Indicated” status, ensuring operations continue without disruption.
- Lupin: Signed a deal with Neopharmed Gentili to market the gastro drug Plasil in the Philippines and Brazil.
- Max Healthcare: The stock emerged as a top gainer at the start of trade, rising 1.91% to reach ₹1,068.50 at 9:20 AM. This surge followed the board’s approval of a major ₹1,020 crore investment plan to establish a new 450 bed super speciality hospital in Pune. The project, located in Yerawada, is expected to be completed over the next three years and marks the company’s significant entry into the Pune healthcare market.
(Source: CNBC TV-18)
Infosys and IT Titans
The technology sector provided a solid foundation for the market’s recovery:
- Infosys (INFY): As of 9:57 AM, December 19, 2025, Infosys Ltd (NSE: INFY) was trading at ₹1,645.60, reflecting a steady gain of ₹18.80 (1.16%) during the morning session.
- HCLTech: The company remained in focus after signing a $160 million agreement to acquire the telecom solutions business of Hewlett Packard Enterprise.
- TCS: On Friday, December 19, 2025, Tata Consultancy Services Ltd (NSE: TCS) was trading at ₹3,308.70 as of 11:11 AM, marking a steady intraday gain of ₹27.90 (0.85%). The stock reached a morning high of ₹3,317.90. This positive momentum is supported by a broader recovery in the Indian IT sector following the company’s focus on expanding its AI-led services.
- Sector Sentiment: Global IT sentiment was bolstered by strong quarterly results from Accenture, which reported a massive 76% surge YoY in generative AI related bookings.
(Source: Moneycontrol, CNBC TV-18)
Infrastructure and Defence Gains
- Aeroflex Industries: Shares jumped to ₹188.10 (+6.09%) after the board approved a ₹55 crore fundraise through a preferential issue of 30.10 lakh shares to investors, including Ashish Kacholia. The funds will support a ₹97.56 crore expansion for liquid cooling skids used in data centres.
- GPT Infra: Secured a major contract worth ₹1,805 crore from MCGM, Mumbai, for flyover construction.
- Mishra Dhatu (Midhani): Secured a new order worth ₹121.75 crore, strengthening its substantial order book.
- Apollo Micro Systems: Its subsidiary, IDL Explosives, received an industrial license to manufacture strategic high energy explosives like HMX and TNT.
(Source: Moneycontrol, CNBC TV-18)
Telecom and Energy Sector
- Vodafone Idea (Vi): Trading at ₹11.49 (+1.68%) following a successful ₹3,300 crore fundraise through its subsidiary, VITIL, via secured non-convertible debentures (NCDs). The proceeds will be used to meet payment obligations to the parent company, enabling boosted capital expenditure.
- Bharti Airtel: Approved calling for the final ₹15,741 crore tranche of its 2021 rights issue to optimise its capital structure.
(Source: Moneycontrol, CNBC TV-18)
New IPO Listings and Market Entries
Today marked the debut of three companies on the SME platforms:
- New IPO Listings: ICICI Prudential AMC, Ashwini Container Movers, and Stanbik Agro officially listed on December 19, 2025 following their successful initial public offerings.
- New F&O Entries: The National Stock Exchange also announced that Swiggy, Waaree Energies, and Premier Energies will soon be available for trading in the Futures and Options (F&O) segment.
(Source: Moneycontrol, Economic Times)
Disclaimer: Investments in the securities market are subject to market risks, read all the related documents carefully before investing. This content is purely for information purpose only and in no way to be considered as an advice or recommendation. The securities are quoted as an example and not as a recommendation.
Investors are requested to do their own due diligence before investing. Paytm Money Ltd SEBI Reg No. Broking – INZ000240532, Depository Participant – IN – DP – 416 – 2019, Depository Participant Number: CDSL – 12088800, NSE (90165), BSE (6707) Regd Office: 136, 1st Floor, Devika Tower, Nehru Place, Delhi – 110019. For complete Terms & Conditions and Disclaimers visit: https://www.paytmmoney.com/stocks/policies/terms .
